These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36917023)

  • 41. Specialty follow -up care after hospital discharge of patients with multisystem inflammatory syndrome in children associated with COVID-19 from a rural tertiary-care hospital.
    Aikman I; Wright B; Applegate S; Whitfield A; Alachraf K; Sridhar S; Tumin D; Syed S
    Pediatr Neonatol; 2024 May; 65(3):266-275. PubMed ID: 37926596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic.
    Young TK; Shaw KS; Shah JK; Noor A; Alperin RA; Ratner AJ; Orlow SJ; Betensky RA; Shust GF; Kahn PJ; Oza VS
    JAMA Dermatol; 2021 Feb; 157(2):207-212. PubMed ID: 33295957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kawasaki disease shock syndrome in the COVID-19 pandemic.
    Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
    Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifying pediatric patients with multisystem inflammatory syndrome in children presenting to a pediatric emergency department.
    Kline JN; Isbey SC; McCollum NL; Falk MJ; Gutierrez CE; Guse SE; Harahsheh AS; Brown KM; Chamberlain JM; Breslin KA
    Am J Emerg Med; 2022 Jan; 51():69-75. PubMed ID: 34688203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan.
    Sethuraman U; Kannikeswaran N; Ang J; Singer A; Miller J; Haddad R; Stankovic C
    Am J Emerg Med; 2021 Jan; 39():164-167. PubMed ID: 33131972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multisystem inflammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study).
    Yilmaz Ciftdogan D; Ekemen Keles Y; Karbuz A; Cetin BS; Elmas Bozdemir S; Kepenekli Kadayifci E; Metin Akcan O; Ozer A; Erat T; Sutcu M; Buyukcam A; Belet N; Erdeniz EH; Dalgic Karabulut N; Hancerli Torun S; Oncel S; Orbak Z; Turel O; Gayretli Aydin ZG; Kilic O; Yahsi A; Kara Aksay A; Ergenc Z; Petmezci MT; Oflaz MB; Sarikaya R; Otar Yener G; Ozen S; Gul D; Arslan G; Kara SS; Demirkol D; Yazici Ozkaya P; Yozgat Y; Varan C; Kara M; Arga G; Yakut N; Kilic AO; Cakici O; Kucuk M; Kaba O; Karaoglu Asrak H; Bursal Duramaz B; Dalkiran T; Berna Anil A; Turgut M; Karapinar B; Somer A; Elmali F; Dinleyici EC; Ciftci E; Kara A
    J Paediatr Child Health; 2022 Jun; 58(6):1069-1078. PubMed ID: 35199895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?
    Santaniello M; Matucci-Cerinic C; Natoli V; Trincianti C; Ridella F; Ravelli A
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):102-104. PubMed ID: 35080303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severity of multisystem inflammatory syndrome in children (MIS-C) in patients with and without mucocutaneous findings.
    Rao M; Bond C; Haggstrom A; Bhumbra S
    Pediatr Dermatol; 2023 Mar; 40(2):294-300. PubMed ID: 36627110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multisystemic Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment.
    Cannon L; Campbell MJ; Wu EY
    Curr Allergy Asthma Rep; 2023 Jun; 23(6):341-350. PubMed ID: 37171672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 in children: Pathogenesis and current status.
    Frenkel LD; Gomez F; Bellanti JA
    Allergy Asthma Proc; 2021 Jan; 42(1):8-15. PubMed ID: 33404385
    [No Abstract]   [Full Text] [Related]  

  • 51. Coronavirus disease 2019-associated multisystem inflammatory syndrome and Kawasaki disease.
    Uejima Y; Suganuma E; Matsunaga K; Kitajima I; Niimi H
    Pediatr Int; 2022 Jan; 64(1):e15349. PubMed ID: 36348517
    [No Abstract]   [Full Text] [Related]  

  • 52. Multisystem Inflammatory Syndrome in Children.
    Tabaac S; Kothari P; Cassidy-Smith T
    J Emerg Med; 2021 Apr; 60(4):531-535. PubMed ID: 33162259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics and treatments of multi-system inflammatory syndrome in children: a systematic review.
    Lee KH; Li H; Lee MH; Park SJ; Kim JS; Han YJ; Cho K; Ha B; Kim SJ; Jacob L; Koyanagi A; Shin JI; Kim JH; Smith L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3342-3350. PubMed ID: 35587087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent Insights into COVID-19 in Children and Clinical Recommendations.
    Castellar-López J; Villamizar-Villamizar W; Amaranto-Pallares A; Rosales-Rada W; De Los Angeles Vélez Verbel M; Chang A; Jiménez FT; Mendoza-Torres E
    Curr Pediatr Rev; 2022; 18(2):121-137. PubMed ID: 34872479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
    Ebina-Shibuya R; Namkoong H; Shibuya Y; Horita N
    Int J Infect Dis; 2020 Aug; 97():371-373. PubMed ID: 32553716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: A systematic review.
    Nascimento RB; Araujo NS; Silva JC; Xavier FCA
    Spec Care Dentist; 2022 May; 42(3):266-280. PubMed ID: 34792813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multisystem inflammatory syndrome in children and SARS-CoV-2: A scoping review.
    Panigrahy N; Policarpio J; Ramanathan R
    J Pediatr Rehabil Med; 2020; 13(3):301-316. PubMed ID: 33252101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit.
    Yagnam R F; Izquierdo C G; Villena M R; González M C; Drago-T M
    Andes Pediatr; 2021 Jun; 92(3):395-405. PubMed ID: 34479246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are we overdiagnosing multisystem inflammatory syndrome in children (MIS-C)? A case series of children with bacterial infection mimicking MIS-C.
    Kumar A; Rajvanshi N; Prabhakaran K; Saini L; Goyal JP; Kumar P
    J Infect Dev Ctries; 2024 May; 18(5):822-825. PubMed ID: 38865386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
    Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
    Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.